Ocular complications with the use of radium-223: a case series

BACKGROUND: Radium-223 is used for the treatment of osseous metastases in castrate-resistant prostate cancer, and has been shown to increase time to the first skeletal-related event, reduce the rate of hospitalization, and improve quality of life. It is well tolerated, with hematologic toxicity as t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bloom, Julie R., Castillejos, Alexandra G., Jones, Brianna, Patel, Nimesh, Rosenstein, Barry S., Stock, Richard G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115982/
https://www.ncbi.nlm.nih.gov/pubmed/35581667
http://dx.doi.org/10.1186/s13014-022-02060-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115982/
https://www.ncbi.nlm.nih.gov/pubmed/35581667
http://dx.doi.org/10.1186/s13014-022-02060-z

Ejemplares similares